PAR paradigm biopharmaceuticals limited..

The Future, page-57

  1. 314 Posts.
    lightbulb Created with Sketch. 123
    Thanks Tommy.

    Elmiron is available as capsules, and in sc injectable format, although it's not commonly prescribed, and is only approved for the treatment of IC.

    My point was that, in my view, $1k - $2k per treatment course, is not a sensible starting point for a revenue projection, if PAR is looking to get this drug available on the PBS.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
41.0¢
Change
-0.010(2.38%)
Mkt cap ! $162.9M
Open High Low Value Volume
42.0¢ 42.3¢ 39.5¢ $453.0K 1.114M

Buyers (Bids)

No. Vol. Price($)
1 49347 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 70000 2
View Market Depth
Last trade - 16.10pm 17/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.